Qiagen N.V. Profile Avatar - Palmy Investing

Qiagen N.V.

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample mater…
Medical - Diagnostics & Research
NL, Venlo [HQ]

Cash Flow Statements

15 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Operating Activities
Operating Cash Flow (OCF)
216.00 250.00 244.00 244.00 258.00 287.00 317.00 341.00 286.00 359.00 330.00 492.00 639.00 715.00 459.00
Operating Cash (Net)
216.00 250.00 244.00 244.00 258.00 287.00 317.00 341.00 286.00 359.00 330.00 492.00 639.00 715.00 459.00
Accounts Receivable
-25.00 -6.00 -28.00 -14.00 -14.00 -16.00 -24.00 -12.00 -34.00 -41.00 -39.00 -14.00 -7.00 15.00 -55.00
Accounts Payable
-9.00 3.00 7.00 -9.00 -6.00 -5.00 7.00 -1.00 4.00 6.00 9.00 8.00 -5.00 -1.00 -22.00
Working Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Investing Activities
Used Cash (Net)
-341.00 -215.00 -540.00 -300.00 -251.00 -407.00 -146.00 -179.00 -464.00 -211.00 -222.00 -453.00 -202.00 -726.00 -87.00
Capital Expenditure
-69.00 -123.00 -121.00 -128.00 -118.00 -97.00 -117.00 -93.00 -124.00 -150.00 -274.00 -304.00 -206.00 -149.00 -162.00
Purchases of Investments
-40.00 -110.00 -206.00 -48.00 -24.00 -429.00 -323.00 -519.00 -455.00 -577.00 -299.00 -50.00 -400.00 -1,387.00 -979.00
Sale/Maturity of Investment
1.00 51.00 242.00 5.00 63.00 275.00 367.00 533.00 189.00 691.00 396.00 207.00 359.00 883.00 1,270.00
Property, Plant, Equipment (P&PE)
-69.00 -123.00 -121.00 -128.00 -118.00 -97.00 -117.00 -93.00 -124.00 -150.00 -274.00 -304.00 -206.00 -149.00 -162.00
Acquisitions (Net)
-234.00 -36.00 -457.00 -131.00 -170.00 -160.00 -66.00 -90.00 -50.00 -172.00 -67.00 -239.00 -16.00 -63.00 -149.00
Other Investing Activities
- - 3.00 2.00 1.00 - - 3.00 -5.00 -8.00 -22.00 -2.00 22.00 -66.00 61.00 -9.00 -66.00
Financing Activities
Used Cash (Net)
-629.00 -35.00 -310.00 -226.00 -68.00 -192.00 -258.00 -10.00 -387.00 -360.00 -639.00 -74.00 -150.00 -125.00 -433.00
Debt Repayment
-27.00 -53.00 -473.00 -150.00 -7.00 -391.00 -252.00 -8.00 -1.00 -1.00 -506.00 -616.00 -41.00 -480.00 -400.00
Dividends Paid
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Common Stock
- - - - - - 52 111 139 20 - - 67 109 76 71 107 25 54
Other Financing Activities
6.00 6.00 154.00 796.00 - - 1,485.00 15.00 -8.00 1,213.00 1,029.00 -60.00 1,220.00 -16.00 404.00 -70.00
Cash Balances
Begin of Period
333.00 825.00 828.00 221.00 394.00 330.00 392.00 290.00 439.00 657.00 1,159.00 628.00 597.00 880.00 730.00
End of Period
825.00 828.00 221.00 394.00 330.00 392.00 290.00 439.00 657.00 1,159.00 629.00 597.00 880.00 730.00 668.00
Change
492.00 2.00 -607.00 172.00 -63.00 62.00 -102.00 149.00 218.00 501.00 -529.00 -31.00 282.00 -149.00 -62.00
Non-Cash Balances
Depreciation and Amortization
120.00 142.00 167.00 197.00 199.00 200.00 191.00 213.00 216.00 206.00 231.00 209.00 214.00 208.00 205.00
Stock Based Compensation
9.00 13.00 19.00 25.00 37.00 42.00 27.00 28.00 34.00 40.00 65.00 40.00 38.00 49.00 47.00
Other
-5.00 -14.00 37.00 -1.00 14.00 47.00 89.00 75.00 23.00 40.00 174.00 165.00 8.00 75.00 41.00
Highlighted metrics
Free Cash Flow (FCF)
147.00 126.00 123.00 116.00 140.00 190.00 200.00 247.00 162.00 208.00 55.00 188.00 432.00 565.00 296.00
Cash Conversion Cycle (CCC)
167.00 147.00 140.00 155.00 143.00 145.00 153.00 145.00 166.00 162.00 162.00 184.00 161.00 180.00 250.00
Invested Capital
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Operating Inflows/Outflows
End of QGEN's Analysis
CIK: 1015820 CUSIP: N72482123 ISIN: NL0015001WM6 LEI: - UEI: -
Secondary Listings